Pharmacologically active compounds in the environment and their chirality

被引:375
|
作者
Kasprzyk-Hordern, Barbara [1 ,2 ]
机构
[1] Univ Huddersfield, Dept Chem & Biol Sci, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England
[2] Univ Bath, Dept Chem, Fac Sci, Bath BA2 7AY, Avon, England
关键词
SOLID-PHASE EXTRACTION; PERSONAL CARE PRODUCTS; TANDEM MASS-SPECTROMETRY; WASTE-WATER TREATMENT; SEWAGE-TREATMENT PLANTS; ENDOCRINE-DISRUPTING COMPOUNDS; SEROTONIN REUPTAKE INHIBITORS; DIFFERENT THERAPEUTIC CLASSES; LIQUID-CHROMATOGRAPHY; ILLICIT DRUGS;
D O I
10.1039/c000408c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pharmacologically active compounds including both legally used pharmaceuticals and illicit drugs are potent environmental contaminants. Extensive research has been undertaken over the recent years to understand their environmental fate and toxicity. The one very important phenomenon that has been overlooked by environmental researchers studying the fate of pharmacologically active compounds in the environment is their chirality. Chiral drugs can exist in the form of enantiomers, which have similar physicochemical properties but differ in their biological properties such as distribution, metabolism and excretion, as these processes (due to stereospecific interactions of enantiomers with biological systems) usually favour one enantiomer over the other. Additionally, due to different pharmacological activity, enantiomers of chiral drugs can differ in toxicity. Furthermore, degradation of chiral drugs during wastewater treatment and in the environment can be stereoselective and can lead to chiral products of varied toxicity. The distribution of different enantiomers of the same chiral drug in the aquatic environment and biota can also be stereoselective. Biological processes can lead to stereoselective enrichment or depletion of the enantiomeric composition of chiral drugs. As a result the very same drug might reveal different activity and toxicity and this will depend on its origin and exposure to several factors governing its fate in the environment. In this critical review a discussion of the importance of chirality of pharmacologically active compounds in the environmental context is undertaken and suggestions for directions in further research are made. Several groups of chiral drugs of major environmental relevance are discussed and their pharmacological action and disposition in the body is also outlined as it is a key factor in developing a full understanding of their environmental occurrence, fate and toxicity. This review will be of interest to environmental scientists, especially those interested in issues associated with environmental contamination with pharmacologically active compounds and chiral pollutants. As the review will outline current state of knowledge on chiral drugs, it will be of value to anyone interested in the phenomenon of chirality, chiral drugs, their stereoselective disposition in the body and environmental fate (212 references).
引用
收藏
页码:4466 / 4503
页数:38
相关论文
共 50 条
  • [41] IRIDOID GLYCOSIDES AS INSECT DEFENSES AND SOURCES FOR PHARMACOLOGICALLY-ACTIVE COMPOUNDS
    STERMITZ, FR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 194 : 180 - AGRO
  • [42] Biocides and pharmacologically active drugs as residues and in the environment: Is there a correlation with antibiotic resistance?
    Russell, AD
    AMERICAN JOURNAL OF INFECTION CONTROL, 2002, 30 (08) : 495 - 498
  • [43] Organic Sulfur Derivatives and Their Metal Complexes as Promising Pharmacologically Active Compounds
    Osipova, V. P.
    Berberova, N. T.
    RUSSIAN JOURNAL OF COORDINATION CHEMISTRY, 2023, 49 (SUPPL 2) : S196 - S232
  • [44] Phytochemical investigation and potential pharmacologically active compounds of Rumex nepalensis: an appraisal
    Gonfa, Yilma Hunde
    Beshah, Fekade
    Tadesse, Mesfin Getachew
    Bachheti, Archana
    Bachheti, Rakesh Kumar
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2021, 10 (01)
  • [45] Highlights on Steroidal Arylidene Derivatives as a Source of Pharmacologically Active Compounds: A Review
    Brito, Vanessa
    Alves, Gilberto
    Almeida, Paulo
    Silvestre, Samuel
    MOLECULES, 2021, 26 (07):
  • [46] Recent Advances in the Development of Pharmacologically Active Compounds that Contain a Benzoxazole Scaffold
    Singh, Sarbjit
    Veeraswamy, Gajulapati
    Bhattarai, Deepak
    Goo, Ja-Il
    Lee, Kyeong
    Choi, Yongseok
    ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2015, 4 (12) : 1338 - 1361
  • [47] Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity
    Arita, Minetaro
    Wakita, Takaji
    Shimizu, Hiroyuki
    JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 2518 - 2530
  • [48] Synthesis of arylpiperazine substituted bisindolylmethanes as possible pharmacologically active new compounds
    Arvas, Busra
    Gunkara, Omer Tahir
    Ocal, Nuket
    ARKIVOC, 2018, : 100 - 109
  • [49] SEARCH FOR PHARMACOLOGICALLY ACTIVE COMPOUNDS AMONG DERIVATIVES OF PHTALAZINE, PYRIDAZINE AND IMIDAZOLE
    MROCZKIEWICZ, A
    ACTA POLONIAE PHARMACEUTICA, 1980, 37 (06): : 699 - 702
  • [50] Organic Sulfur Derivatives and Their Metal Complexes as Promising Pharmacologically Active Compounds
    V. P. Osipova
    N. T. Berberova
    Russian Journal of Coordination Chemistry, 2023, 49 : S196 - S232